Trexquant Investment’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-62,503
Closed -$312K 1555
2021
Q3
$312K Buy
+62,503
New +$360K 0.02% 721
2020
Q1
Sell
-35,807
Closed -$196K 1342
2019
Q4
$196K Buy
+35,807
New +$202K 0.01% 925
2018
Q1
Sell
-17,579
Closed -$203K 1309
2017
Q4
$203K Buy
+17,579
New +$262K 0.02% 940
2016
Q1
Sell
-86,688
Closed -$2.59M 1113
2015
Q4
$2.59M Buy
+86,688
New +$2.92M 0.23% 99
2015
Q3
Sell
-9,384
Closed -$453K 1214
2015
Q2
$453K Buy
+9,384
New +$395K 0.05% 662
2015
Q1
Sell
-12,870
Closed -$338K 1135
2014
Q4
$338K Buy
+12,870
New +$282K 0.06% 642

Other funds holding PGEN

Trexquant Investment's PGEN Position: Q4 2021 in Review

Trexquant Investment sold out of Precigen (PGEN) in Q4 2021, closing a stake of 62,503 shares — an estimated $312K sold.

Trexquant Investment first reported a position in PGEN in Q4 2014 and held it in 6 quarters. The position peaked at $2.59M in Q4 2015. 168 funds tracked by Wall St. Rank hold PGEN as of Q4 2021.

  • Trexquant Investment reported no remaining Precigen position as of Q4 2021 after selling out during the quarter.
  • Trexquant Investment sold 62,503 Precigen shares in Q4 2021, an estimated $312K.
  • Trexquant Investment first reported a position in Precigen in Q4 2014 and held it in 6 quarters.
  • Trexquant Investment's Precigen position peaked at $2.59M in Q4 2015.
  • 168 funds tracked by Wall St. Rank held Precigen as of Q4 2021.

Based on Trexquant Investment's 13F filing for Q4 2021, filed 14 Feb 2022.